Ignite Creation Date:
2024-05-05 @ 9:53 PM
Last Modification Date:
2024-10-26 @ 10:11 AM
Study NCT ID:
NCT00989586
Status:
COMPLETED
Last Update Posted:
2017-02-06
First Post:
2009-10-02
Brief Title:
Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Sponsor:
Beth Christian
Organization:
Ohio State University Comprehensive Cancer Center
Organization Data
Organization:
Ohio State University Comprehensive Cancer Center
Class:
OTHER
Study ID:
OSU-09024
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beth Christian
Lead Sponsor Class:
OTHER
Responsible Party:
Beth Christian
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Ohio State University Comprehensive Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Gilead Sciences | INDUSTRY |